MIRAE ASSET SECURITIES (USA) INC.’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-201,666
Closed -$12.3M 193
2025
Q4
$12.3M Buy
+201,666
New +$24.5M 0.34% 66
2025
Q2
Sell
-100,000
Closed -$11.2M 244
2025
Q1
$11.2M Buy
+100,000
New +$10.3M 0.31% 89
2024
Q4
Sell
-53,300
Closed -$4.47M 185
2024
Q3
$4.47M Buy
53,300
+11,800
+28% +$900K 0.18% 92
2024
Q2
$2.85M Buy
+41,500
New +$2.77M 0.13% 118

Other funds holding GILD

MIRAE ASSET SECURITIES (USA) INC.'s GILD Position: Q1 2026 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 100,833 shares — an estimated $12.4M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in GILD in Q2 2024 and held it in 4 quarters. The position peaked at $12.4M in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 100,833 Gilead Sciences shares in Q1 2026, an estimated $12.4M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Gilead Sciences in Q2 2024 and held it in 4 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Gilead Sciences position peaked at $12.4M in Q4 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q1 2026, filed 29 Apr 2026.